Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-04-27 Taylor Stacy L SVP and General Counsel Option exercise +11,270 $6.55 $74K 20,880
2020-04-27 Taylor Stacy L SVP and General Counsel Sale −19,580 $30.22 $592K 1,300
2020-04-27 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −8,310 41,690
2020-04-27 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −11,270 40,730
2020-04-23 HERSHBERG ROBERT Director Option exercise +25,000 $0.45 $11K 25,000
2020-04-23 HERSHBERG ROBERT Director Sale −25,000 $29.77 $744K 0
2020-04-23 HERSHBERG ROBERT Director Option exercise · Stock Option (Right to Buy) −25,000 75,000
2020-04-22 ROBINS HARLAN S Chief Scientific Officer Option exercise +25,600 $6.32 $162K 96,279
2020-04-22 ROBINS HARLAN S Chief Scientific Officer Sale −100 $29.63 $3K 96,179
2020-04-22 ROBINS HARLAN S Chief Scientific Officer Sale −25,500 $30.28 $772K 70,679
2020-04-22 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −25,600 511,200
2020-04-21 ROBINS HARLAN S Chief Scientific Officer Option exercise +3,900 $6.32 $25K 74,579
2020-04-21 ROBINS HARLAN S Chief Scientific Officer Sale −1,203 $28.55 $34K 73,376
2020-04-21 ROBINS HARLAN S Chief Scientific Officer Sale −2,697 $29.50 $80K 70,679
2020-04-21 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −3,900 536,800
2020-04-20 Cohen Chad M Chief Financial Officer Option exercise +5,000 $6.32 $32K 6,000
2020-04-20 Cohen Chad M Chief Financial Officer Option exercise +5,000 $4.07 $20K 11,000
2020-04-20 Cohen Chad M Chief Financial Officer Sale −10,000 $30.00 $300K 1,000
2020-04-20 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −5,000 30,000
2020-04-20 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −5,000 740,000

Page 108 of 120 · 2,386 trades